Skip to main content
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. logo

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings

Ticker · 000661 ISIN · CNE0000007J8 LEI · 300300X04OTKZG18WD66 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2023-02-24 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 000661

About CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

https://ccht.jl.cn

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.

Recent filings

Filing Released Lang Actions
关于2022年限制性股票与股票期权激励计划部分限制性股票注销完成的公告
Transaction in Own Shares Classification · 95% confidence The document is an official announcement from Changchun High-tech Industry (Group) Co., Ltd. regarding the completion of the repurchase and cancellation of part of the 2022 restricted stock and stock option incentive plan. It details the number of shares repurchased and cancelled, the reasons for the repurchase, the approval procedures, the impact on share capital structure, and the verification of funds used for the repurchase. The document is a formal disclosure about a share repurchase and cancellation related to an equity incentive plan, including specific share counts, prices, and approvals. It is not a full financial report, earnings release, or management discussion, nor is it a proxy statement or voting result announcement. It fits the category of a Transaction in Own Shares (POS) because it reports the company's buyback and cancellation of its own shares under an incentive plan. The document length (5250 characters) and detailed content confirm it is the actual announcement of the transaction, not just a brief notice or report publication announcement.
2023-02-24 Chinese
关于子公司签订科研合作框架协议的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement about a subsidiary signing a scientific research cooperation framework agreement. It contains no financial data, no regulatory form references, no financial results, and no detailed report content. The length is only 653 characters, indicating it is a brief announcement. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is an announcement of a corporate event related to cooperation agreements, which is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-02-22 Chinese
关于部分董事增持公司股份的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding a company director (ZHU JEFF XIANCHAO) increasing his shareholding in the company. It details the number of shares bought, the price, and compliance with relevant laws and regulations. There is no financial report, earnings data, or management discussion. The content fits the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives.
2023-02-21 Chinese
关于控股子公司聚乙二醇重组人生长激素注射液药品补充申请获得批准的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Changchun High-tech Industry Group Co., Ltd. regarding the approval of a supplementary drug application by the National Medical Products Administration. It is a regulatory announcement about product approval and related risks, not a financial report, management change, or shareholder meeting material. The document length is only 496 characters, indicating it is a brief announcement. It does not contain financial data, earnings, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement.
2023-02-21 Chinese
北京大成（长春）律师事务所关于长春高新技术产业（集团）股份有限公司2023年第一次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the legality of the procedures and results of the 2023 first extraordinary general meeting (临时股东大会) of Changchun High-tech Industry (Group) Co., Ltd. It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or management discussion but focuses on the legal validation of the shareholder meeting process and voting outcomes. It is not a report of the meeting itself, nor an announcement of voting results in a formal shareholder announcement format, but a legal opinion letter on the meeting's legality. This type of document is best classified under Regulatory Filings (RNS) as it is a compliance/legal filing related to corporate governance and shareholder meetings but does not fit the more specific categories such as Declaration of Voting Results (DVA) or Board/Management Information (MANG). The document length is under 5,000 characters, but it is a substantive legal opinion, not a mere announcement or certification, so RNS is appropriate.
2023-02-16 Chinese
2023年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from the company's first extraordinary general meeting of shareholders in 2023. It details the meeting date, voting methods, attendance, voting results, and legal opinions confirming the validity of the meeting and resolutions. There is no financial data or report content, only the official announcement of the voting results and meeting resolutions. The document length is short (1803 characters), and it serves as an official disclosure of shareholder meeting decisions. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-02-16 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.